Figure 5.

Survival analysis in ICIAM. (A) Overall survival analysis for immune check point inhibitor-associated myopathy (ICIAM) versus immune-mediated necrotizing myopathy (IMNM), demonstrating significant lower survival for ICIAM. (B) Survival comparison for ICIAM-related deaths between oculobulbar versus generalized ICIAM subgroup. (C) ICIAM patients who required intubation have reduced survival compared to non-intubated ICIAM patients. (D) There is a trend for lower survival in ICIAM patients with respiratory insufficiency compared to those without. (E) Survival analysis also shows a trend for lower survival in ICIAM patients with myocarditis compared to those without. (F) Survival analysis of patients with positive striational antibodies shows a trend for lower survival compared to seronegative patients. Cardiac In = cardiac involvement; Gen = generalized; Int. = intubation; Neg = negative; Oculob = oculobulbar; Pos. = positive; Res. In. = respiratory involvement; STR = striational antibodies.